| 4 | BlackRock, Inc. | 2.7M | $175.2M | +462.8% | 3.595% | 0.00% |
| 5 | TANG CAPITAL MANAGEMENT LLC | 2.3M | $144.5M | 0.0% | 2.966% | 6.56% |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.9M | $122.2M | +8.2% | 2.508% | 0.01% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 1.4M | $87.0M | +2.1% | 1.786% | 0.00% |
| 8 | MORGAN STANLEY | 1.0M | $64.7M | +1.3% | 1.327% | 0.00% |
| 9 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 958K | $61.2M | +7.3% | 1.256% | 0.03% |
| 10 | Spruce Street Capital LP | 918K | $58.7M | +20.6% | 1.205% | 11.52% |
| 11 | DIMENSIONAL FUND ADVISORS LP | 875K | $55.9M | +7.7% | 1.148% | 0.01% |
| 12 | Invesco Ltd. | 773K | $49.4M | +2694.3% | 1.014% | 0.00% |
| 13 | DRIEHAUS CAPITAL MANAGEMENT LLC | 718K | $45.9M | +17.5% | 0.942% | 0.27% |
| 14 | STATE STREET CORP | 704K | $45.0M | +818.9% | 0.924% | 0.00% |
| 15 | Point72 Asset Management, L.P. | 659K | $42.2M | +2.9% | 0.865% | 0.05% |
| 16 | RICE HALL JAMES & ASSOCIATES, LLC | 625K | $40.0M | +2.7% | 0.820% | 1.95% |
| 17 | Pictet Asset Management Holding SA | 609K | $38.9M | -2.4% | 0.799% | 0.04% |
| 18 | GEODE CAPITAL MANAGEMENT, LLC | 604K | $38.6M | +1263.2% | 0.793% | 0.00% |
| 19 | Jupiter Topco LLC | 586K | $37.5M | — | 0.769% | 0.02% |
| 20 | Connor, Clark & Lunn Investment Management Ltd. | 573K | $36.6M | -11.9% | 0.751% | 0.07% |
| 21 | D. E. Shaw & Co., Inc. | 570K | $36.4M | -40.6% | 0.748% | 0.02% |
| 22 | TWO SIGMA INVESTMENTS, LP | 561K | $35.9M | +33.4% | 0.737% | 0.03% |
| 23 | VICTORY CAPITAL MANAGEMENT INC | 505K | $32.3M | -0.3% | 0.662% | 0.02% |
| 24 | BNP PARIBAS FINANCIAL MARKETS | 437K | $28.0M | -32.5% | 0.574% | 0.01% |
| 25 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 431K | $27.6M | -1.5% | 0.566% | 0.01% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in KNSA — a direct measure of their conviction.
| 55.82% |
| +1.31 pp |
| $848M |
| +14% |
| Q4 2024 | 156 | 9.8% | 54.51% | 1.18 pp | $747M | 23% |
| Q3 2024 | 173 | — | 55.69% | — | $967M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
65 institutions opened new positions in KNSA during Q2 2026, while 27 fully exited. 152 added to existing positions and 40 trimmed.
KNSA institutional ownership rose by 0.16 percentage points quarter-over-quarter, with a net change of +39 holders.
The top 10 institutions account for 54.5% of all reported 13F value in KNSA, and the top 25 account for 74.7%.
Across the largest Immunology Biotech peers, institutional ownership levels are: LKFT (49.6%), YARW (1.2%), RKTO (7.9%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.